Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States

被引:13
作者
LeBrett, Wendi G. [1 ,2 ]
Chen, Frank W. [1 ,2 ]
Yang, Liu [1 ,2 ]
Chang, Lin [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA
关键词
IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; ABDOMINAL-PAIN; PRESCRIBING PATTERNS; CHRONIC-PANCREATITIS; SYMPTOM SEVERITY; NARCOTIC USE; USE DISORDER; MANAGEMENT; GASTROENTEROLOGY;
D O I
10.14309/ajg.0000000000001052
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Pain control is an important management approach for many gastrointestinal conditions. Because of the ongoing opioid crisis, public health efforts have focused on limiting opioid prescriptions. This study examines national opioid prescribing patterns and factors associated with opioid prescriptions for gastrointestinal conditions. METHODS: We conducted a repeated cross-sectional study using the National Ambulatory Medical Care Survey data from 2006 to 2016. The International Classification of Diseases codes were used to identify ambulatory visits with a primary gastrointestinal diagnosis. Data were weighted to calculate national estimates for opioid prescriptions for gastrointestinal disease. Joinpoint regression was used to analyze temporal trends. Multivariable logistic regression was used to examine factors associated with opioid prescriptions. RESULTS: We analyzed 12,170 visits with a primary gastrointestinal diagnosis, representing 351 million visits. The opioid prescription rate for gastrointestinal visits was 10.1% (95% confidence interval [CI] 9.0%-11.2%). Opioid prescription rates for gastrointestinal disease increased by 0.5% per year from 2006 to 2016 (P = 0.04). Prescription rates were highest for chronic pancreatitis (25.1%) and chronic liver disease (13.9%) visits. Seventy-one percent of opioid prescriptions were continuations of an existing prescription. Patient characteristics associated with continued opioid prescriptions included rural location (adjusted odds ratio [aOR] 1.46; 95% CI 1.11-1.93), depression (aOR 1.83; 95% CI 1.33-2.53), and Medicaid insurance (aOR 1.57; 95% CI 1.15-2.13). DISCUSSION: Opioid prescription rates for gastrointestinal disease visits increased from 2006 to 2016. Our findings suggest an inadequate response to the opioid epidemic by providers managing gastrointestinal conditions. Further clinical interventions are needed to limit opioid use for gastrointestinal disease. [GRAPHICS] .
引用
收藏
页码:796 / 807
页数:12
相关论文
共 65 条
[61]   Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders [J].
Törnblom H. ;
Drossman D.A. .
Current Gastroenterology Reports, 2018, 20 (12)
[62]  
U.S. Department of Health and Human Services, 2019, EP
[63]   Pain severity and pain catastrophizing predict functional disability in youth with inflammatory bowel disease [J].
Wojtowicz, Andrea A. ;
Greenley, Rachel Neff ;
Gumidyala, Amitha Prasad ;
Rosen, Andrew ;
Williams, Sara E. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (09) :1118-1124
[64]   Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015 [J].
Wren, Anava A. ;
Bensen, Rachel ;
Sceats, Lindsay ;
Dehghan, Melody ;
Yu, Helen ;
Wong, Jessie J. ;
MacIsaac, Donna ;
Sellers, Zachary M. ;
Kin, Cindy ;
Park, K. T. .
INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) :2093-2103
[65]   Initial Opioid Prescriptions among US Commercially Insured Patients, 2012-2017 [J].
Zhu, Wenjia ;
Chernew, Michael E. ;
Sherry, Tisamarie B. ;
Maestas, Nicole .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (11) :1043-1052